161Tb-PSMA Unleashed: a Promising New Player in the Theranostics of Prostate Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Link
https://link.springer.com/content/pdf/10.1007/s13139-023-00804-7.pdf
Reference26 articles.
1. Roy I, Krishnan S, Kabashin AV, Zavestovskaya IN, Prasad PN. Transforming nuclear medicine with nanoradiopharmaceuticals. ACS Nano. 2022;16:5036–61.
2. Lee DS, Cheon GJ. Nuclear theranostics in Asia: in vivo companion diagnostics. Nucl Med Mol Imaging. 2019;53:1–6.
3. Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, et al. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer. 2021;146:56–73.
4. Hirmas N, Jadaan R, Al-Ibraheem A. Peptide receptor radionuclide therapy and the treatment of gastroentero-pancreatic neuroendocrine tumors: current findings and future perspectives. Nucl Med Mol Imaging. 2018;52:190–9.
5. Mullard A. FDA approves first PSMA-targeted radiopharmaceutical. Nat Rev Drug Discov. 2022;21:327.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanostructures and nanoparticles as medical diagnostic imaging contrast agents: A review;Materials Today Chemistry;2024-09
2. How to Harness the Power of GPT for Scientific Research: A Comprehensive Review of Methodologies, Applications, and Ethical Considerations;Nuclear Medicine and Molecular Imaging;2024-08-12
3. Internal dosimetry assessment of beta, beta/auger, and alpha decaying radionuclides in targeted radionuclide therapy for prostate cancer: a simulation study;Physica Scripta;2024-07-30
4. Review on the Increasing Role for PSMA-Based Radioligand Therapy in Prostate Cancer;Cancers;2024-07-12
5. Navigating The Prostate Cancer Frontier: A Bibliometric and Altmetric Analysis of [225Ac]Ac-PSMA Therapy;Seminars in Nuclear Medicine;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3